Comparison of Different Surgical Approaches in Female Rectal Cancer.
NCT07189780 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2025-09-24
Summary
Mid-to-low rectal cancer exhibits an extremely high incidence rate in China. Currently, the primary treatment approach for mid-to-low rectal cancer remains surgical intervention, with total mesorectal excision (TME) being the mainstream procedure. In male patients, Heald, Chi Pan , Wei Hongbo , and others have proposed different dissection techniques for the anterior rectal wall. Partial or complete preservation of Denonvilliers Fascia (DVF) during conventional TME (as proposed by Heald) has been shown to significantly reduce intraoperative bleeding and improve postoperative urodynamic function, urinary continence, and sexual function . However, these studies focused exclusively on male patients and did not include female subjects.
In our previous research, we proposed that females do not possess an anatomical structure equivalent to the male DVF. Furthermore, compared to entering the dissection plane by incising the peritoneum 0.5-1 cm above the lowest point of the peritoneal reflection, initiating the peritoneal incision precisely at the lowest point of the peritoneal reflection better ensures the integrity of the mesorectum and vaginal structures, reduces intraoperative bleeding, provides a more favorable operative field, and avoids damage to physiological structures while ensuring complete tumor resection, thereby promoting postoperative recovery. Thus, we concluded that this plane represents the optimal surgical dissection plane for the anterior rectal wall during TME in female patients with mid-to-low rectal cancer without anterior wall invasion.
Since our prior study combined anatomical and clinical retrospective research, we have initiated a prospective multicenter randomized controlled trial to further validate these clinical findings. This study aims to demonstrate that entering the dissection plane at the lowest point of the peritoneal reflection during mid-to-low rectal cancer surgery improves prognosis in female patients, providing high-level evidence-based medical support for the adoption of this technique and establishing the optimal surgical approach for female rectal cancer patients.
Conditions
- Rectal Cancer Surgery
Interventions
- PROCEDURE
-
Surgical approach
Control Group:Incising the peritoneum 0.5-1 cm above the lowest point of the peritoneal reflection to enter the dissection plane. Experimental Group:Incising the peritoneum precisely at the lowest point of the peritoneal reflection (in the rectovesical or rectouterine pouch) to enter the dissection plane.
Sponsors & Collaborators
-
Wuhan TongJi Hospital
collaborator OTHER -
Zhejiang Cancer Hospital
collaborator OTHER -
Fudan University
collaborator OTHER -
First Affiliated Hospital of Wenzhou Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2027-08-31
- Completion
- 2030-08-01
More Related Trials
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer
NCT04743102 ·Status: RECRUITING ·Phase: NA
-
Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.
NCT06613399 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
NCT05871762 ·Status: RECRUITING
-
Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer
NCT05671809 ·Status: NOT_YET_RECRUITING
-
Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)
NCT06194708 ·Status: RECRUITING
-
Transanal Total Mesorectal Excision Versus Robotic Total Mesorectal Excision
NCT04091620 ·Status: UNKNOWN ·Phase: NA
-
A Trial of Robotic-assisted Versus Laparoscopic Abdominoperineal Resection for Treating Low Rectal Cancer
NCT01985698 ·Status: COMPLETED ·Phase: NA
-
Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response
NCT03846726 ·Status: COMPLETED
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
NCT02649647 ·Status: RECRUITING ·Phase: NA
-
Cross-sectional Study of Anorectal Function and Quality of Life in Patients With Middle and Low Rectal Cancer
NCT04697303 ·Status: COMPLETED
-
Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer
NCT03359616 ·Status: UNKNOWN ·Phase: NA
-
Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal Cancer
NCT04573738 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low Site
NCT03253302 ·Status: UNKNOWN
-
Study of Intramural Spread Pattern in Low Rectal Cancer.
NCT07202169 ·Status: COMPLETED
-
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
NCT05496270 ·Status: COMPLETED
-
A Study on the Efficacy of a Novel Approach to Achieving Laparoscopic Distal Rectal Transection for Rectal Cancers
NCT05067413 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer
NCT00949273 ·Status: UNKNOWN
-
Simple Transanal Local Excision,Transanal Local Excision Following Radiotherapy Versus Total Mesorectum Excision for the Treatment of the Ultra-low T2N0M0 Rectal Cancer
NCT04098471 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Feasibility and Safety of No-scar Transanal Total Mesorectal Excision for Rectal Cancer
NCT02236884 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nurse-or Surgeon-led Follow-up After Rectal Cancer
NCT01045200 ·Status: COMPLETED
-
Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer
NCT01271192 ·Status: UNKNOWN ·Phase: NA
-
Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors
NCT03177382 ·Status: UNKNOWN ·Phase: PHASE3
-
Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer
NCT06454201 ·Status: COMPLETED ·Phase: NA